No significant differences in baseline clinical parameters were observed between patients with PD HCC and those with well differentiated (WD) or MD HCC (p = 0.103–1.000), except for serum AFP level (p = 0.010). The gene discussed is AFP; the disease is hepatocellular carcinoma.